Format

Send to

Choose Destination
Dis Model Mech. 2019 Feb 22;12(2). pii: dmm039271. doi: 10.1242/dmm.039271.

From gene to treatment: supporting rare disease translational research through model systems.

Author information

1
Disease Models & Mechanisms, The Company of Biologists, Bidder Building, Station Road, Histon, Cambridge CB24 9LF, UK.
2
Program in Genetics and Genome Biology, The Hospital for Sick Children, and Department of Molecular Genetics, The University of Toronto, Toronto, Ontario M5G 0A4 Canada monica.justice@sickkids.ca.

Abstract

Individual rare diseases may affect only a few people, making them difficult to recognize, diagnose or treat by studying humans alone. Instead, model organisms help to validate genetic associations, understand functional pathways and develop therapeutic interventions for rare diseases. In this Editorial, we point to the key parameters in face, construct, predictive and target validity for accurate disease modelling, with special emphasis on rare disease models. Raising the experimental standards for disease models will enhance successful clinical translation and benefit rare disease research.

KEYWORDS:

Clinical translation; Disease model; Face validity; Genome editing; Rare disease

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center